Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Market Cap	44.01B
Revenue (ttm)	79.90B
Net Income (ttm)	2.89B
Shares Out	1.63B
EPS (ttm)	1.78
PE Ratio	9.65
Forward PE	8.52
Dividend	0.86 (5.05%)
Ex-Dividend Date	Oct 15, 2024

Volume	126,000
Average Volume	679,943
Open	17.18
Previous Close	17.18
Day's Range	17.18 - 17.28
52-Week Range	15.76 - 24.20
Beta	0.52
RSI	54.60
Earnings Date	Apr 30, 2025

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical ins...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 28,048
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0874

Financial Performance

In 2024, HKG:0874's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY